Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to $50.8 million.

  • Ocular Therapeutix's Total Current Liabilities rose 2285.63% to $50.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $50.8 million, marking a year-over-year increase of 2285.63%. This contributed to the annual value of $50.8 million for FY2025, which is 2285.63% up from last year.
  • Per Ocular Therapeutix's latest filing, its Total Current Liabilities stood at $50.8 million for Q4 2025, which was up 2285.63% from $49.3 million recorded in Q3 2025.
  • Ocular Therapeutix's Total Current Liabilities' 5-year high stood at $50.8 million during Q4 2025, with a 5-year trough of $21.6 million in Q2 2021.
  • For the 5-year period, Ocular Therapeutix's Total Current Liabilities averaged around $32.8 million, with its median value being $30.7 million (2022).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 14691.32% in 2021, then plummeted by 1822.99% in 2024.
  • Quarter analysis of 5 years shows Ocular Therapeutix's Total Current Liabilities stood at $26.3 million in 2021, then increased by 19.2% to $31.4 million in 2022, then increased by 11.15% to $34.9 million in 2023, then increased by 18.51% to $41.4 million in 2024, then rose by 22.86% to $50.8 million in 2025.
  • Its Total Current Liabilities was $50.8 million in Q4 2025, compared to $49.3 million in Q3 2025 and $42.9 million in Q2 2025.